BOOK
Surgery For Benign Oesophageal Disorders
Simic Aleksandar P | Bonavina Luigi | Demeester Steven R
(2017)
Additional Information
Book Details
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Contents | xi | ||
Preface | v | ||
About the Editors | vii | ||
Chapter 1. Perspectives of Surgery for Benign Esophageal Diseases | 1 | ||
1.1. Introduction | 1 | ||
1.2. Patient Related [2, 4] | 2 | ||
1.3. Related to Intervention [2, 4] | 2 | ||
1.4. Related to Comparison [2, 4] | 3 | ||
1.5. Related to Outcomes [2, 4] | 3 | ||
References | 7 | ||
Chapter 2. Fundoplication for Gastroesophageal Reflux Disease | 11 | ||
2.1. Introduction | 11 | ||
2.2. Clinical Aspects | 13 | ||
2.3. Pre-operative Evaluation | 14 | ||
2.4. Indications | 16 | ||
2.5. Persistent Dilemma: Type of Fundoplication | 17 | ||
2.6. Laparoscopic Nissen Fundoplication | 19 | ||
2.6.1. Patient positioning and trocar placement | 19 | ||
2.6.2. Hiatal dissection | 20 | ||
2.6.3. Crural repair and fundus mobilization | 21 | ||
2.6.4. Fundoplication | 22 | ||
2.7. Post-operative Care | 23 | ||
2.8. Complications | 24 | ||
2.9. Results | 25 | ||
2.10. Conclusion | 26 | ||
References | 26 | ||
Chapter 3. Innovations in Minimally Invasive Therapy of GERD\r | 35 | ||
3.1. Introduction | 35 | ||
3.2. Endoscopic Anti-reflux Procedures | 36 | ||
3.2.1. Evolution | 36 | ||
3.2.2. Endoscopic plication | 37 | ||
3.2.3. Remarks on endoscopic plication | 39 | ||
3.3. Magnetic Sphincter Augmentation | 40 | ||
3.3.1. Evolution | 40 | ||
3.3.2. LINX\x02 implantation | 41 | ||
3.3.3. Clinical data | 41 | ||
3.3.4. LINX\x02 vs. laparoscopic fundoplication | 43 | ||
3.3.5. Summary | 44 | ||
3.4. Electrical Sphincter Stimulation | 45 | ||
3.4.1. Evolution | 45 | ||
3.4.2. EndoStim implantation | 45 | ||
3.4.3. Clinical outcomes | 46 | ||
3.4.4. Summary | 48 | ||
References | 48 | ||
Chapter 4. Reflux Strictures and Short Esophagus | 55 | ||
4.1. Introduction | 55 | ||
4.2. Pathophysiology of GERD and Its Relationship with RS and SE | 56 | ||
4.3. Reflux Strictures | 58 | ||
4.3.1. Clinical presentation of RS | 59 | ||
4.3.2. Diagnosis of RS | 59 | ||
4.3.3. Treatment of RS | 61 | ||
4.4. Short Esophagus | 62 | ||
4.4.1. The clinical “Problem” of SE | 63 | ||
4.4.2. Pre-operative suspicion of SE | 64 | ||
4.4.3. Intraoperative diagnosis of SE | 64 | ||
4.4.4. Treatment of the SE | 65 | ||
4.4.5. Surgical results | 67 | ||
References | 68 | ||
Chapter 5. Surgical Management of Paraesophageal Hernia\r | 73 | ||
5.1. Introduction | 73 | ||
5.2. Pathogenesis and Natural History | 74 | ||
5.3. Symptoms and Diagnosis | 75 | ||
5.4. Indications for Surgical Therapy | 77 | ||
5.5. Principles of SurgicalManagement | 78 | ||
5.5.1. Standard surgical approach | 80 | ||
References | 82 | ||
Chapter 6. Failed Anti-Reflux Surgery | 85 | ||
6.1. Introduction | 85 | ||
6.2. Types of Anti-reflux Surgery Failure | 85 | ||
6.3. Anatomic Failure | 86 | ||
6.4. Functional Failure | 87 | ||
6.5. Diagnostics of Failed Anti-reflux Surgery | 87 | ||
6.6. Treatment of Failed Anti-reflux Surgery | 88 | ||
6.7. Conclusion | 89 | ||
References | 89 | ||
Chapter 7. Definition and Significance of Barrett’s Esophagus | 91 | ||
7.1. History | 91 | ||
7.2. The Definition of Barrett’s Esophagus (BE) | 92 | ||
7.3. Significance of the Diagnosis of BE | 93 | ||
7.3.1. The severity of reflux in BE | 93 | ||
7.3.2. Relevance of esophagitis | 94 | ||
7.3.3. Decisions on long-term therapy—medical or surgical | 94 | ||
7.3.4. Risk of cancer | 95 | ||
7.3.5. Natural history of BE | 95 | ||
7.3.6. The question of annual surveillance endoscopy | 96 | ||
7.3.7. Geographical variations | 96 | ||
7.4. DiagnosticMethods in BE | 97 | ||
7.4.1. Standard histology | 97 | ||
7.4.1.1. Cytosponge | 97 | ||
7.4.2. Other markers | 98 | ||
7.5. Immediate Impact of the Diagnosis | 98 | ||
7.6. Quality of Surveillance Endoscopy | 99 | ||
References | 100 | ||
Chapter 8. Endoscopic Therapy for Barrett’s Esophagus: Who and How? | 105 | ||
8.1. Introduction | 105 | ||
8.2. Radiofrequency Ablation | 106 | ||
8.2.1. RFA 360 and RFA 360 express | 107 | ||
8.2.2. Focal electrode tip Tip-mounted RFA (60, 90) | 109 | ||
8.2.3. Via the scope platelet electrode “the eagle” | 110 | ||
8.3. EndoscopicMucosal Resection | 110 | ||
8.3.1. Endoscopic submucosal dissection | 112 | ||
8.4. Results After RFA ± EMR | 112 | ||
8.4.1. Non-dysplastic BE | 112 | ||
8.4.2. BE and low-grade dysplasia | 115 | ||
8.4.3. BE and high-grade dysplasia/early cancer | 116 | ||
8.4.4. Post-RFA medical therapy | 117 | ||
8.4.5. RFA and anti-reflux surgery | 118 | ||
8.4.6. Follow-up after RFA | 119 | ||
8.5. Contraindications for RFA | 120 | ||
8.6. Cryoablation | 120 | ||
8.7. Hybrid-Argon Plasma Coagulation | 122 | ||
8.8. Conclusion | 122 | ||
References | 123 | ||
Chapter 9. Current Treatment Strategies in Barrett’s Esophagus | 133 | ||
9.1. Introduction | 133 | ||
9.2. PPI Treatment of BE | 135 | ||
9.3. Barrett’s Esophagus and Anti-reflux Surgery | 137 | ||
9.4. Treatment after Endoscopic Removal of BE | 140 | ||
9.5. Conclusion | 144 | ||
References | 144 | ||
Chapter 10. Chicago Classification: Impact of HRM on the Diagnosis and Management of Esophageal Motility Disorders | 149 | ||
10.1. Introduction | 149 | ||
10.2. Chicago Classification v.3.0 | 150 | ||
10.2.1. Upper esophageal sphincter | 152 | ||
10.2.2. Esophageal body | 152 | ||
10.2.2.1. Contraction vigor | 152 | ||
10.2.2.2. Peristalsis | 152 | ||
10.2.3. Lower esophageal sphincter | 153 | ||
10.2.3.1. Esophagogastric morphology | 154 | ||
10.2.4. Intrabolus pressure pattern | 155 | ||
10.3. High-ResolutionManometry NamedMotility Disorders According to the Chicago Classification | 156 | ||
10.4. High-Resolution Manometry and Clinical Utility of Chicago \rClassification: Parameters | 159 | ||
10.5. Classification of Motility Disorders | 163 | ||
10.6. Critical Analysis of the Impact of HRM on the Diagnosis of Esophageal Motility Disorders\r | 164 | ||
10.7. Critical Analysis of the Impact of HRM on theManagement of Esophageal Motility Disorders | 165 | ||
10.7.1. Achalasia | 165 | ||
10.7.2. Esophagogastric junction outflow obstruction | 166 | ||
10.7.3. Major disorders of peristalsis | 166 | ||
10.7.3.1. Absent contractility | 166 | ||
10.7.3.2. Distal esophageal spasm | 167 | ||
10.7.3.3. Hypercontractile esophagus | 167 | ||
10.7.4. Minor disorders of peristalsis | 167 | ||
10.7.4.1. Ineffective esophageal motility | 167 | ||
10.7.4.2. Fragmented peristalsis | 168 | ||
10.8. Conclusions | 168 | ||
References | 168 | ||
Chapter 11. Is There a Role for Endoscopic Therapy in Achalasia? | 173 | ||
11.1. Introduction | 173 | ||
11.2. Botulinum Toxin (BoT) Injections | 177 | ||
11.3. Endoscopic Pneumatic Dilation | 179 | ||
11.3.1. TheWitzel dilator | 180 | ||
11.3.2. The rigiflex dilator | 181 | ||
11.4. Pneumatic Dilatation vs. Laparoscopic HellerMyotomy (LHM) | 188 | ||
11.5. Other Endoscopic Techniques | 190 | ||
11.5.1. Esophageal self-expanding metal stents | 190 | ||
11.5.2. Endoscopic sclerotherapy | 191 | ||
11.5.3. Peroral endoscopic myotomy (POEM) | 191 | ||
11.6. Conclusions | 191 | ||
References | 193 | ||
Chapter 12. POEM in the Treatment of Primary Esophageal Motility Disorders | 201 | ||
12.1. Development of POEM | 201 | ||
12.2. The Technique | 201 | ||
12.3. Indications and Contraindications | 203 | ||
12.4. Achalasia | 204 | ||
12.5. Nutcracker Esophagus | 207 | ||
12.6. Jackhammer Esophagus | 207 | ||
12.7. Distal Esophageal Spasm | 208 | ||
12.8. Other Benign Disorders | 208 | ||
12.9. Conclusion | 208 | ||
References | 209 | ||
Chapter 13. Surgery for Achalasia | 215 | ||
13.1. Introduction | 215 | ||
13.2. Length of Myotomy | 217 | ||
13.3. Significance of Fundoplication | 218 | ||
13.4. Type of Fundoplication | 219 | ||
13.5. Surgical Technique and Post-operative Follow-up | 221 | ||
13.6. Predictors of Outcome and SymptomRecurrence | 224 | ||
13.7. End-stage Achalasia | 228 | ||
13.8. New Trends in Surgery for Achalasia: The Future? | 229 | ||
References | 230 | ||
Chapter 14. Management of Esophageal Epiphrenic Diverticula | 239 | ||
14.1. Introduction | 239 | ||
14.2. Treatment | 240 | ||
14.3. Surgical Principles | 240 | ||
14.3.1. Myotomy | 240 | ||
14.3.2. Fundoplication | 241 | ||
14.3.3. Diverticulectomy | 241 | ||
14.3.4. Post-operative treatment | 241 | ||
14.4. Minimally Invasive Surgery? | 242 | ||
14.4.1. Techniques | 242 | ||
14.4.2. Results of treatment | 243 | ||
14.5. Conclusions | 243 | ||
References | 243 | ||
Chapter 15. Minimally InvasiveManagement of Benign Esophageal Tumors and Cysts | 245 | ||
15.1. Introduction | 245 | ||
15.2. Leiomyoma | 246 | ||
15.2.1. Symptoms | 246 | ||
15.2.2. Diagnosis | 247 | ||
15.2.3. Treatment | 248 | ||
15.3. Esophageal Cyst | 253 | ||
15.3.1. Symptoms and diagnosis | 253 | ||
15.3.2. Treatment | 253 | ||
15.4. Conclusions | 254 | ||
References | 254 | ||
Chapter 16. Management of Caustic Gastroesophageal Injuries | 257 | ||
16.1. Introduction | 257 | ||
16.2. Epidemiology | 257 | ||
16.3. Corrosive Agents | 258 | ||
16.4. EmergencyManagement of Caustic Ingestion | 258 | ||
16.4.1. Pre-hospital management | 258 | ||
16.4.2. Emergency department management | 259 | ||
16.4.3. Evaluation of the severity of caustic injuries | 259 | ||
16.4.3.1. Clinical presentation | 259 | ||
16.4.3.2. Laboratory studies | 260 | ||
16.4.3.3. Endoscopy | 260 | ||
16.4.3.4. Computed tomography | 261 | ||
16.4.4. Management algorithm | 261 | ||
16.4.5. Non-operative management | 262 | ||
16.4.6. Emergency surgery | 263 | ||
16.4.6.1. Esophagogastrectomy | 264 | ||
16.4.6.2. Total gastrectomy | 265 | ||
16.4.6.3. Extended resections | 265 | ||
16.4.6.4. Tracheobronchial necrosis | 266 | ||
16.4.7. Outcomes of emergency surgery for caustic ingestion | 266 | ||
16.5. Delayed Complications of Corrosive Ingestion | 266 | ||
16.5.1. Upper digestive bleeding | 267 | ||
16.5.2. Corrosive aspiration pneumonia | 267 | ||
16.5.3. Fistula formation | 267 | ||
16.5.4. Caustic strictures | 267 | ||
16.5.4.1. Gastric strictures | 268 | ||
16.5.4.2. Esophageal strictures | 268 | ||
16.5.4.3. Pharyngeal strictures | 269 | ||
16.5.5. Malignancy | 269 | ||
16.6. Esophageal Reconstruction | 269 | ||
16.6.1. Pre-operative evaluation | 269 | ||
16.6.2. Intraoperative management and operative outcomes | 270 | ||
16.6.3. Late outcomes of esophageal reconstruction | 271 | ||
16.7. Conclusion | 272 | ||
References | 272 | ||
Chapter 17. ContemporaryManagement of Iatrogenic and Non-iatrogenic Esophageal Injuries | 279 | ||
17.1. Introduction | 279 | ||
17.2. ClinicalManifestations | 280 | ||
17.3. Diagnosis | 280 | ||
17.3.1. Laboratory findings | 280 | ||
17.3.2. Cervical and thoracic radiography | 280 | ||
17.3.3. Contrast esophagogram | 281 | ||
17.3.4. Computed tomography | 281 | ||
17.3.5. Upper GI endoscopy | 281 | ||
17.3.6. Differential diagnosis | 281 | ||
17.4. Management | 281 | ||
17.4.1. Non-operative management | 282 | ||
17.4.2. Endoscopic management | 283 | ||
17.4.3. Surgical management | 283 | ||
17.4.3.1. Primary surgical repair | 284 | ||
17.4.3.2. Diversion | 285 | ||
17.4.3.3. Esophagectomy | 285 | ||
17.4.3.4. Drainage only | 286 | ||
17.5. Outcomes | 286 | ||
17.6. Traumatic Perforation | 287 | ||
References | 287 | ||
Index | 291 |